CollPlant Biotechnologies Shares Outstanding 2017-2021 | CLGN

CollPlant Biotechnologies shares outstanding from 2017 to 2021. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
CollPlant Biotechnologies Annual Shares Outstanding
(Millions of Shares)
2020 7
2019 5
2018 4
2017 3
2016 2
CollPlant Biotechnologies Quarterly Shares Outstanding
(Millions of Shares)
2021-06-30 10
2021-03-31 8
2020-12-31 7
2020-09-30 7
2020-06-30 7
2020-03-31 7
2019-12-31 5
2019-09-30 5
2019-06-30 5
2019-03-31 5
2018-12-31 4
2018-09-30 5
2018-06-30 4
2018-03-31 3
2017-12-31 3
2017-09-30 2
2017-06-30 3
2017-03-31 3
2016-12-31 2
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.000B $0.006B
CollPlant Biotechnologies Ltd. is a regenerative medicine company. It is focused on 3D bioprinting of tissues and organs, medical aesthetics and on developing and commercializing tissue repair products for orthobiologics and advanced wound care markets. CollPlant Biotechnologies Ltd., formerly knonw as CollPlant Holdings Ltd., is based in Rehovot, Israel.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.838B 8.91
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.341B 20.90
Biohaven Pharmaceutical Holding (BHVN) United States $8.723B 0.00
Emergent Biosolutions (EBS) United States $2.813B 6.79
Arcus Biosciences (RCUS) United States $2.568B 0.00
Myovant Sciences (MYOV) United Kingdom $2.170B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.949B 0.00
Zymeworks (ZYME) Canada $1.323B 0.00
Ambrx Biopharma (AMAM) United States $0.509B 0.00
SQZ Biotechnologies (SQZ) United States $0.428B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29